UCB Australia Pty Ltd.
🇦🇺Australia
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
36
TGA:36
Drug Approvals
Bimzelx bimekizumab 320 mg/2 mL solution for injection safety syringe (443491)
- Product Name
- BIMZELX bimekizumab 320 mg/2 mL solution for injection safety syringe
- Approval Date
- Apr 8, 2025
TGA
Bimzelx bimekizumab 320 mg/2 mL solution for injection auto-injector (443490)
- Product Name
- BIMZELX bimekizumab 320 mg/2 mL solution for injection auto-injector
- Approval Date
- Apr 8, 2025
TGA
RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial (427684)
- Product Name
- RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial
- Approval Date
- Feb 7, 2025
TGA
FINTEPLA fenfluramine 2.2 mg/mL Oral Solution Bottle (429413)
- Product Name
- FINTEPLA fenfluramine 2.2 mg/mL Oral Solution Bottle
- Approval Date
- Nov 28, 2024
TGA
ZILBRYSQ zilucoplan (as tetrasodium) 16.6 mg/ 0.416 mL solution for injection pre-filled syringe (410994)
- Product Name
- ZILBRYSQ zilucoplan (as tetrasodium) 16.6 mg/ 0.416 mL solution for injection pre-filled syringe
- Approval Date
- Aug 20, 2024
TGA
ZILBRYSQ zilucoplan (as tetrasodium) 32.4 mg/ 0.810 mL solution for injection pre-filled syringe (414649)
- Product Name
- ZILBRYSQ zilucoplan (as tetrasodium) 32.4 mg/ 0.810 mL solution for injection pre-filled syringe
- Approval Date
- Aug 20, 2024
TGA
ZILBRYSQ zilucoplan (as tetrasodium) 23.0 mg/ 0.574 mL solution for injection pre-filled syringe (414648)
- Product Name
- ZILBRYSQ zilucoplan (as tetrasodium) 23.0 mg/ 0.574 mL solution for injection pre-filled syringe
- Approval Date
- Aug 20, 2024
TGA
Bimzelx bimekizumab 160 mg/1 mL solution for injection auto-injector (353268)
- Product Name
- BIMZELX bimekizumab 160 mg/1 mL solution for injection auto-injector
- Approval Date
- Mar 24, 2022
TGA
Bimzelx bimekizumab 160 mg/1 mL solution for injection safety syringe (353269)
- Product Name
- BIMZELX bimekizumab 160 mg/1 mL solution for injection safety syringe
- Approval Date
- Mar 24, 2022
TGA
VIMPAT lacosamide 10 mg/mL oral solution bottle (286810)
- Product Name
- VIMPAT lacosamide 10 mg/mL oral solution bottle
- Approval Date
- Aug 14, 2018
TGA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found